- Home
- ETON vs GNSS Comparison
ETON vs GNSS Comparison
Compare ETON & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- GNSS
- Stock Information
- Founded
- ETON 2017
- GNSS 1992
- Country
- ETON United States
- GNSS United States
- Employees
- ETON N/A
- GNSS N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- GNSS Consumer Electronics/Appliances
- Sector
- ETON Health Care
- GNSS Consumer Staples
- Exchange
- ETON Nasdaq
- GNSS Nasdaq
- Market Cap
- ETON 199.5M
- GNSS 169.5M
- IPO Year
- ETON 2018
- GNSS N/A
- Fundamental
- Price
- ETON $8.82
- GNSS $3.75
- Analyst Decision
- ETON Strong Buy
- GNSS Strong Buy
- Analyst Count
- ETON 3
- GNSS 3
- Target Price
- ETON $12.00
- GNSS $5.08
- AVG Volume (30 Days)
- ETON 214.1K
- GNSS 106.7K
- Earning Date
- ETON 11-11-2024
- GNSS 12-05-2024
- Dividend Yield
- ETON N/A
- GNSS N/A
- EPS Growth
- ETON N/A
- GNSS N/A
- EPS
- ETON N/A
- GNSS N/A
- Revenue
- ETON $31,381,000.00
- GNSS $27,968,000.00
- Revenue This Year
- ETON $19.61
- GNSS N/A
- Revenue Next Year
- ETON $35.39
- GNSS $138.10
- P/E Ratio
- ETON N/A
- GNSS N/A
- Revenue Growth
- ETON 8.14
- GNSS N/A
- 52 Week Low
- ETON $3.03
- GNSS $1.51
- 52 Week High
- ETON $8.66
- GNSS $4.04
- Technical
- Relative Strength Index (RSI)
- ETON 76.07
- GNSS 60.29
- Support Level
- ETON $7.58
- GNSS $3.67
- Resistance Level
- ETON $8.66
- GNSS $3.94
- Average True Range (ATR)
- ETON 0.42
- GNSS 0.14
- MACD
- ETON -0.07
- GNSS -0.02
- Stochastic Oscillator
- ETON 91.49
- GNSS 77.78
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About GNSS Genasys Inc.
Genasys Inc is a provider of critical communications solutions designed to help keep people safe. The company is engaged in the design, development, and commercialization of directed and multidirectional sound technologies, voice broadcast products and location-based mass messaging solutions for emergency warning and workforce management. Its operating segment includes Hardware and Software. The company generates maximum revenue from the Hardware segment. Geographically, it derives a majority of revenue from the Americas region and also has its presence in the Asia Pacific and Europe, Middle East and Africa.